Sibanye Stillwater Ltd (SBSW) Stock Price Today
Aura AI Summary
Key Stats
- $7.86BMarket Cap
- 3,191,650Volume
- Basic MaterialsSector
- $21.1252W High
- $8.0052W Low
- 50 DaysTypical Hold Time
- $8.77BEnterprise Value
- 8.13%Div Yield
- 43% Sell | 57% BuyTrading Activity
Track Sibanye Stillwater Ltd (SBSW) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Sibanye Stillwater Ltd has traded between a low of $8 and a high of $21.12, highlighting its annual price range. Buy and sell Sibanye Stillwater Ltd shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Sibanye Stillwater Ltd
Sibanye Stillwater Ltd is a South Africa-focused mining company. The Group currently owns and operates five underground and surface gold operations in South Africa: the Cooke, DRDGOLD, Driefontein, and Kloof operations in the West Witwatersrand region, and the Beatrix Operation in the southern Free State province. In addition to mining, the company owns and manages extraction and processing facilities at its operations, where gold-bearing ore is treated and beneficiated to produce gold dore. The gold dore is further refined at Rand Refinery into gold bars with a purity of at least 99.5% and is then sold on international markets. Sibanye holds a 44% interest in Rand Refinery, global refiners of gold, and the largest in Africa. Rand Refinery markets gold to customers around the world.
Most Recent News
Five stocks drop over 10% on Oct 5, led by Sphere Entertainment downgrade and C.H. Robinson acquisition news.
On October 5, 2026, five notable stocks experienced double-digit declines. Sphere Entertainment fell 13.6% after a downgrade from Craig-Hallum, while C.H. Robinson dropped 10.9% following its announcement to acquire RXO for $5.8 billion. Velo3D, Boos...

GMAB's Rina-S shows 45.9% response in ovarian cancer trial, advancing to Phase 3 studies.
GMAB's investigational drug Rina-S demonstrated a 45.9% confirmed response rate in a Phase 1/2 trial for platinum-resistant ovarian cancer, with a median response duration of 12.1 months and median progression-free survival of 9.5 months. Despite ser...

Lucid Motors cuts EV production 54% in Q3 amid weak demand and cost-cutting efforts
Lucid Motors produced 2,954 electric vehicles in Q3 2026, down 54% from a year earlier, as it intentionally limited output to better match weak demand. This marks the third consecutive quarter of declining production and the lowest since early 2025. ...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.